
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
[ Thu, Oct 28th 2021 ]: WOPRAI
Tiago Fauth Maintained (BMRN) at Buy with Decreased Target to $100 on, Oct 28th, 2021


🞛 This publication is a summary or evaluation of another publication
Tiago Fauth of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $102 to $100 on, Oct 28th, 2021.
Tiago has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $88 on, Thursday, July 29th, 2021
This is the rating of the analyst that currently disagrees with Tiago
- Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $96 on, Thursday, September 9th, 2021